Cargando…
Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study
BACKGROUND: There is limited data on the use of anti-TNF agents in patients with concomitant cirrhosis. The aim of this study is to assess the safety of anti-TNF agents in patients with compensated cirrhosis who used these medications for the treatment of an underlying rheumatologic condition or IBD...
Autores principales: | Kapila, Nikhil, Gonzalez, Adalberto, Rosado, Jose Melendez, Flocco, Gianina, Salomon, Fayssa, Abusaif, Mohammad, Hussain, Ishtiaq, Moor, Molly A., Modaresi-Esfeh, Jamak, Castro, Fernando J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543557/ https://www.ncbi.nlm.nih.gov/pubmed/34707687 http://dx.doi.org/10.1177/17562848211037094 |
Ejemplares similares
-
The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
por: Kapila, Nikhil, et al.
Publicado: (2018) -
Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016) -
Unusual MRI appearance of a well differentiated hepatocellular carcinoma, mimicking a cavernous hemangioma: A case report
por: Ansari-Gilani, Kianoush, et al.
Publicado: (2019) -
Ciliated hepatic foregut cyst: report of three cases and review of imaging features
por: Ansari-Gilani, Kianoush, et al.
Publicado: (2017) -
Work up of fatty liver by primary care physicians, review
por: Rikhi, Rishi, et al.
Publicado: (2020)